Glucagon Antibody (49) - BSA Free

Glucagon-like peptide-1(9-36)amide and GLP-1(9-37) are the forms of GLP-1 that result from the rapid degradation of the active forms of the peptide (GLP-1(7-36)amide and GLP-1(7-37)) by the enzyme dipeptidyl peptidase-IV (DPP-IV, also known as CD26 or adenosine deaminase binding protein). GLP-1 is a peptide hormone of the glucagon family, produced by the L cells of the intestinal mucosa from the same prohormone as glucagon. The active forms are potent stimulators of glucose-dependent insulin secretion. The sequence of GLP-1 is fully conserved in all mammalian species examined so far.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Showing Publications 1 - 2 of 2.

Publications using NBP2-23591	Applications	Species
Chendke G, Kharbikar B, Ashe S et al. Replenishable prevascularized cell encapsulation devices increase graft survival and function in the subcutaneous space Bioengineering & Translational Medicine 2023-05-19 [PMID: 37476069]
Winn NC, Cottam MA, Bhanot M Et al. Weight Cycling Impairs Pancreatic Insulin Secretion but Does Not Perturb Whole-Body Insulin Action in Mice With Diet-Induced Obesity Diabetes 2022-07-08 [PMID: 35802127] Details: Citation using the HRP version of this antibody.

Array NBP2-23591

• Glucagon Antibodies
• Glucagon Lysate
• Glucagon Proteins
• Glucagon ELISAs